Cardiovascular disease due to accelerated atherosclerosis in systemic vasculitides

Best Practice and Research: Clinical Rheumatology

Volumn 27, Issue 1, 2013, Pages 33-44

  Cohen Tervaert, Jan Willem ^a,b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b SINT FRANCISCUS GASTHUIS   (Netherlands)

Author keywords

Acetylsalicylic acid; ANCA; Atherosclerosis; Kawasaki disease; Myeloperoxidas; Proteinase 3; Statins; Takayasu arteritis; Vasculitis

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; ARYLDIALKYLPHOSPHATASE; AZATHIOPRINE; C REACTIVE PROTEIN; CREATINE KINASE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EZETIMIBE; FIBRIC ACID DERIVATIVE; GAMMA INTERFERON; GLUCOCORTICOID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROXYCHLOROQUINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; IMMUNOGLOBULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHOTREXATE; NICOTINIC ACID; PREDNISOLONE; PROTON PUMP INHIBITOR; TOCILIZUMAB; TORCETRAPIB; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR INHIBITOR; UNINDEXED DRUG;

ABDOMINAL OBESITY; ALCOHOL CONSUMPTION; ANCA ASSOCIATED VASCULITIS; AORTA ARCH SYNDROME; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; AUTOIMMUNITY; BLOOD VESSEL REACTIVITY; BRACHIAL ARTERY; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAROTID ARTERY; CEREBROVASCULAR ACCIDENT; CERVICAL LYMPHADENOPATHY; CHOLESTEROL BLOOD LEVEL; CORTICOSTEROID THERAPY; DIABETES MELLITUS; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; ERYTHROCYTE SEDIMENTATION RATE; FAMILIAL HYPERCHOLESTEROLEMIA; FEEDING BEHAVIOR; GENETIC RISK; GIANT CELL ARTERITIS; HUMAN; HYPERTENSION; IMMOBILIZATION; IMMUNE RESPONSE; INFLAMMATION; INNATE IMMUNITY; ISCHEMIC HEART DISEASE; KIDNEY DYSFUNCTION; LIPID OXIDATION; LOW DRUG DOSE; META ANALYSIS (TOPIC); MICROSCOPIC POLYANGIITIS; MORBIDITY; MUCOCUTANEOUS LYMPH NODE SYNDROME; NONHUMAN; PLETHYSMOGRAPHY; POLYARTERITIS NODOSA; PRESCRIPTION; PRIORITY JOURNAL; PROTEINURIA; REGULATORY T LYMPHOCYTE; SMOKING; SURVIVAL; SYSTEMIC VASCULITIS; T LYMPHOCYTE ACTIVATION; TH1 CELL; TRIACYLGLYCEROL BLOOD LEVEL; WEGENER GRANULOMATOSIS;

EID: 84875169882     PISSN: 15216942     EISSN: 15321770     Source Type: Journal    
DOI: 10.1016/j.berh.2012.12.004     Document Type: Review

References (86)

1. G.K. Hansson, and A. Hermansson The immune system in atherosclerosis Nature Immunology 12 2011 204 212
2. J.W. Tervaert Translational mini-review series on immunology of vascular disease: accelerated atherosclerosis in vasculitis Clinical and Experimental Immunology 15 2009 377 385
3. J.W. Tervaert, and C.G. Kallenberg Cell adhesion molecules in vasculitis Current Opinion In Rheumatology 9 1997 16 25
4. N. Del Papa, L. Guidali, A. Sala, C. Buccellati, M.A. Khamashta, and K. Ichikawa Endothelial cells as target for antiphospholipid antibodies. Human polyclonal and monoclonal anti-beta 2-glycoprotein I antibodies react in vitro with endothelial cells through adherent beta 2-glycoprotein I and induce endothelial activation Arthritis and Rheumatism 40 1997 551 561
5. A.C. Muller Kobold, R.T. van Wijk, C.F. Franssen, G. Molema, C.G. Kallenberg, and J.W. Tervaert In vitro up-regulation of E-selectin and induction of interleukin-6 in endothelial cells by autoantibodies in Wegener's granulomatosis and microscopic polyangiitis Clinical and Experimental Rheumatology 17 1999 433 440
6. M.A. Little, and C.O. Savage The role of the endothelium in systemic small vessel vasculitis Clinical and Experimental Rheumatology 26 Suppl. 49 2008 S135 S140
7. C. Belizna, and J.W. Tervaert Specificity, pathogenecity, and clinical value of antiendothelial cell antibodies Seminars In Arthritis and Rheumatism 27 1997 98 109
8. K.S. Eardley, S.W. Smith, and P. Cockwell Chemokines in vasculitis Frontiers In Bioscience 1 2009 26 35
9. M. van Leeuwen, M.J. Gijbels, A. Duijvestijn, M. Smook, M.J. van de Gaar, and P. Heeringa Accumulation of myeloperoxidase-positive neutrophils in atherosclerotic lesions in LDLR-/- mice Arteiosclerosis, Thrombosis, and Vascular Biology 28 2008 84 89
10. S.J. Nicholls, and S.L. Hazen Myeloperoxidase, modified lipoproteins, and Atherogenesis Journal of Lipid Research 50 Suppl. 2009 S346 S351
11. B. Shao, M.N. Oda, J.F. Oram, and J.W. Heinecke Myeloperoxidase: an oxidative pathway for generating dysfunctional high-density lipoprotein Chemical Research In Toxicology 23 2010 447 454
12. H. Zinger, Y. Sherer, and Y. Shoenfeld Atherosclerosis in autoimmune rheumatic diseases-mechanisms and clinical findings Clinical Reviews In Allergy & Immunology 37 2009 20 28
13. G. Liuzzo, J.J. Goronzy, H. Yang, S.L. Kopecky, D.R. Holmes, and R.L. Frye Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes Circulation 101 2000 2883 2888
14. J.J. Goronzy, H. Fujii, and C.M. Weyand Telomeres, immune aging and autoimmunity Experimental Gerontology 41 2006 246 251
15. B. Wilde, M. Thewissen, J. Damoiseaux, P. van Paassen, O. Witzke, and J.W. Tervaert T cells in ANCA-associated vasculitis: what can we learn from lesional versus circulating T cells? Arthritis Research & Therapy 12 1 2010 204
16. W.H. Abdulahad, A.M. Boots, and C.G. Kallenberg FoxP3+ CD4+ T cells in systemic autoimmune diseases: the delicate balance between true regulatory T cells and effector Th-17 cells Rheumatology (Oxford) 50 4 2011 Apr 646 656
17. B. Wilde, M. Thewissen, J. Damoiseaux, M. Hilhorst, P. van Paassen, and O. Witzke. Th17 expansion in granulomatosis with polyangiitis (Wegener's): the role of disease activity, immune regulation and therapy Arthritis Research & Therapy 14 5 2012 Oct 18 R227
18. D.R. Petermann Smits, B. Wilde, M. Kianersi Adegani, H. de Jongh, P. van Paassen, and J.W. Cohen Tervaert Metabolic syndrome in ANCA-associated vasculitis Rheumatology (Oxford) 52 2013 197 203
19. J. Jennette, R. Falk, P. Bacon, N. Basu, M. Cid, and F. Ferrario 2012 revised international chapel hill consensus conference nomenclature of vasculitides Arthritis and Rheumatism 65 2013 1 11
20. C. Mukhtyar, L. Guillevin, M.C. Cid, B. Dasgupta, K. de Groot, and W. Gross European Vasculitis Study Group. EULAR recommendations for the management of large vessel vasculitis Annals of The Rheumatic Diseases 68 2009 318 323
21. V.S. Schäfer, and J. Zwerina Biologic treatment of large-vessel vasculitides Current Opinion In Rheumatology 24 2012 31 37
22. E.L. Matteson, K.N. Gold, D.A. Bloch, and G.G. Hunder Long-term survival of patients with giant cell arteritis in the American College of Rheumatology giant cell arteritis classification criteria cohort American Journal of Medicine 100 1996 193 196
23. M.A. Gonzalez-Gay, R. Blanco, V. Abraira, C. García-Porrúa, D. Ibáñez, and M.J. García-Pais Giant cell arteritis in Lugo, Spain, is associated with low longterm mortality Journal of Rheumatology 24 1997 2171 2176
24. J. Ninan, A.M. Nguyen, A. Cole, M. Rischmueller, T. Dodd, and P. Roberts-Thomson Mortality in patients with biopsy-proven giant cell arteritis: a south australian population-based study Journal of Rheumatology 38 2011 2215 2217
25. M.A. Gonzalez-Gay, T.R. Vazquez-Rodriguez, I. Gomez-Acebo, R. Pego-Reigosa, M.J. Lopez-Diaz, and M.C. Vazquez-Triñanes Strokes at time of disease diagnosis in a series of 287 patients with biopsy-proven giant cell arteritis Medicine (Baltimore) 88 2009 227 235
26. C. Gonzalez-Juanatey, J. Llorca, C. Garcia-Porrua, A. Sanchez-Andrade, J. Martín, and M.A. Gonzalez-Gay Steroid therapy improves endothelial function in patients with biopsy-proven giant cell arteritis Journal of Rheumatology 33 2006 74 78
27. M.A. Gonzalez-Gay Glucocorticoid-related cardiovascular and cerebrovascular events in rheumatic diseases: myth or reality? Arthritis and Rheumatism 57 2007 191 192
28. C. Gonzalez-Juanatey, M.J. Lopez-Diaz, J. Martin, J. Llorca, and M.A. Gonzalez-Gay Atherosclerosis in patients with biopsy-proven giant cell arteritis Arthritis and Rheumatism 57 2007 1481 1486
29. A. Filer, D. Nicholls, R. Corston, P. Carey, and P. Bacon Takayasu arteritis and atherosclerosis: illustrating the consequences of endothelial damage Journal of Rheumatology 28 2001 2752 2753
30. E. Seyahi, S. Ugurlu, R. Cumali, H. Balci, N. Seyahi, and S. Yurdakul Atherosclerosis in Takayasu arteritis Annals of The Rheumatic Diseases 65 2006 1202 1207
31. F. Numano, M. Okawara, H. Inomata, and Y. Kobayashi Takayasu's arteritis Lancet 356 2000 1023 1025
32. R.O. Raninen, M.M. Kupari, and P.E. Hekali Carotid and femoral artery stiffness in Takayasu's arteritis. An Ultrasound Study Scand Journal of Rheumatology 31 2002 85 88
33. I.J. Cho, C.Y. Shim, W.I. Yang, S.A. Kim, H.J. Chang, and Y. Jang Assessment of mechanical properties of common carotid artery in Takayasu's arteritis using velocity vector imaging Circulation Journal 74 2010 1465 1470
34. J. Hwang, S.J. Kim, O.Y. Bang, C.S. Chung, K.H. Lee, and D.K. Kim Ischemic stroke in Takayasu's arteritis: lesion patterns and possible mechanisms Journal of Clinical Neurology 8 2012 109 115
35. M. Rav-Acha, L. Plot, N. Peled, and H. Amital Coronary involvement in Takayasu's arteritis Autoimmunity Reviews 6 2007 566 571
36. M.E. Soto, G. Meléndez-Ramírez, E. Kimura-Hayama, A. Meave-Gonzalez, S. Achenbach, and M.C. Herrera Coronary CT angiography in Takayasu arteritis JACC Cardiovascular Imaging 4 2011 958 966
37. R. Dhillon, P. Clarkson, A.E. Donald, A.J. Powe, M. Nash, and V. Novelli Endothelial dysfunction late after Kawasaki disease Circulation 94 1996 2103 2106
38. B.W. McCrindle, S. McIntyre, C. Kim, T. Lin, and K. Adeli Are patients after Kawasaki disease at increased risk for accelerated atherosclerosis? Journal of Pediatrics 151 2007 244 248
39. N. Noto, T. Okada, M. Yamasuge, K. Taniguchi, K. Karasawa, and M. Ayusawa Noninvasive assessment of the early progression of atherosclerosis in adolescents with Kawasaki disease and coronary artery lesions Pediatrics 107 2001 1095 1099
40. Y.F. Cheung, S.J. Wong, and M.H. Ho Relationship between carotid intima-media thickness and arterial stiffness in children after Kawasaki disease Archives of Disease In Childhood 92 2007 43 47
41. J.M. Orenstein, S.T. Shulman, L.M. Fox, S.C. Baker, M. Takahashi, and T.R. Bhatti Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic study PLoS One 7 2012 e38998
42. N. Noto, T. Okada, Y. Abe, M. Miyashita, H. Kanamaru, and K. Karasawa Characteristics of earlier atherosclerotic involvement in adolescent patients with Kawasaki disease and coronary artery lesions: significance of gray scale median on B-mode ultrasound Atherosclerosis 222 2012 106 109
43. B. Wilde, P. van Paassen, O. Witzke, and J.W. Tervaert New pathophysiological insights and treatment of ANCA-associated vasculitis Kidney International 79 2011 599 612
44. J.W. Cohen Tervaert, and J. Damoiseaux Antineutrophil cytoplasmic autoantibodies: how are they detected and what is their use for diagnosis, classification and follow-up? Clinical Reviews In Allergy & Immunology 43 2012 211 219
45. R. Luqmani, R. Suppiah, C.J. Edwards, R. Phillip, J. Maskell, and D. Culliford Mortality in Wegener's granulomatosis: a bimodal pattern Rheumatology (Oxford) 50 2011 697 702
46. C. Heijl, L. Harper, O. Flossmann, I. Stücker, D.G. Scott, and R.A. Watts European Vasculitis Study Group (EUVAS). Incidence of malignancy in patients treated for antineutrophil cytoplasm antibody-associated vasculitis: follow-up data from European Vasculitis Study Group clinical trials Annals of the Rheumatic Diseases 70 2011 1415 1421
47. R. Suppiah, A. Judge, R. Batra, O. Flossmann, L. Harper, and P. Höglund A model to predict cardiovascular events in patients with newly diagnosed wegener's granulomatosis and microscopic polyangiitis Arthritis Care and Research (Hoboken) 2011 [Epub ahead of print]
48. M. Faurschou, L. Mellemkjaer, I.J. Sorensen, B. Svalgaard Thomsen, L. Dreyer, and B. Baslund Increased morbidity from ischemic heart disease in patients with Wegener's granulomatosis Arthritis and Rheumatism 60 2009 1187 1192
49. M.D. Morgan, J. Turnbull, U. Selamet, M. Kaur-Hayer, P. Nightingale, and C.J. Ferro Increased incidence of cardiovascular events in patients with antineutrophil cytoplasmic antibody-associated vasculitides: a matched-pair cohort study Arthritis and Rheumatism 60 2009 3493 3500
50. K. Raza, J. Thambyrajah, J.N. Townend, A.R. Exley, C. Hortas, and A. Filer Suppression of inflammation in primary systemic vasculitis restores vascular endothelial function: lessons for atherosclerotic disease? Circulation 102 2000 1470 1472
51. A.D. Booth, D.R. Jayne, R.K. Kharbanda, C.M. McEniery, I.S. Mackenzie, and J. Brown Infliximab improves endothelial dysfunction in systemic vasculitis: a model of vascular inflammation Circulation 109 2004 1718 1723
52. I.N. Bruce, C.M. Harris, A. Nugent, B.J. McDermott, G.D. Johnston, and A.L. Bell Enhanced endothelium-dependent vasodilator responses in patients with systemic vasculitis Scandinavian Journal of Rheumatology 26 1997 318 324
53. H.L. Nienhuis, K. de Leeuw, A.J. Smit, J. Bijzet, C.A. Stegeman, and C.G. Kallenberg Enhanced endothelium-dependent microvascular responses in patients with Wegener's granulomatosis Journal of Rheumatology 34 2007 1875 1881
54. A.D. Booth, S. Wallace, C.M. McEniery, Yasmin, J. Brown, and D.R. Jayne Inflammation and arterial stiffness in systemic vasculitis: a model of vascular inflammation Arthritis and Rheumatism 50 2004 581 588
55. S.R. Sangle, R.J. Davies, M. Mora, M.A. Baron, G.R. Hughes, and D.P. D'Cruz. Ankle-brachial pressure index: a simple tool for assessing cardiovascular risk in patients with systemic vasculitis Rheumatology (Oxford) 47 2008 1058 1060
56. J.W. Cohen Tervaert Cholesterol and modifications of cholesterol in rheumatic disorders G.S. Hoffman, C.M. Weyand, C.A. Langford, J.J. Gorozny, Inflammatory diseases of blood vessels 2nd ed. 2012 Wiley-Blackwell 475 483
57. J. Heinecke HDL and cardiovascular-disease risk-time for a new approach? The New England Journal of Medicine 364 2011 171
58. B.H. Hahn, J. Grossman, B.J. Ansell, B.J. Skaggs, and M. McMahon Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis Arthritis Research & Therapy 10 2008 213
59. A. Kontush, and M.J. Chapman Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and athersclerosis Pharmacological Reviews 58 2006 342 374
60. P.J. Barter, M. Caulfield, M. Eriksson, S.M. Grundy, J.J. Kastelein, M. Komajda ILLUMINATE Investigators Effects of torcetrapib in patients at high risk for coronary events The New England Journal of Medicine 357 2007 2109 2122
61. M. McMahon, J. Grossman, J. FitzGerald, E. Dahlin-Lee, D.J. Wallace, and B.Y. Thong Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis Arthritis and Rheumatism 54 2006 2541 2549
62. T. Quéméneur, F. Martin-Nizard, A. Kandoussi, X. Kyndt, P. Vanhille, and E. Hachulla PON1, a new biomarker of cardiovascular disease, is low in patients with systemic vasculitis Seminars In Arthritis and Rheumatism 37 2007 149 155
63. N. Espinola-Zavaleta, M.E. Soto-López, E. Carreón-Torres, R. Gamboa, A.M. Mejía, and R. Márquez-Velasco Altered flow-mediated vasodilatation, low paraoxonase-1 activity, and abnormal high-density lipoprotein subclass distribution in Takayasu's arteritis Circulation Journal 73 2009 760 766
64. S.C. Bergheanu, A. Van Tol, G.M. Dallinga-Thie, A. Liem, P.H. Dunselman, and J.G. Van der Bom Effect of rosuvastatin versus atorvastatin treatment on paraoxonase-1 activity in men with established cardiovascular disease and a low HDL-cholesterol Current Medical Research and Opinion 23 2007 2235 2240
65. W.T. Donahoo, L.A. Kosmiski, and R.H. Eckel Drugs causing dyslipoproteinemia Endocrinology and Metabolism Clinics of North America 27 1998 677 697
66. M. Petri, S. Perez-Gutthann, D. Spence, and M.C. Hochberg Risk factors for coronary artery disease in patients with systemic lupus erythematosus American Journal of Medicine 93 1992 513 519
67. G. Steiner, and M.B. Urowitz Lipid profiles in patients with rheumatoid arthritis: mechanisms and the impact of treatment Seminars In Arthritis and Rheumatism 38 2009 372 381
68. M.J. Peters, M. Vis, V.P. Van Halm, G.J. Wolbink, A.E. Voskuyl, and W.F. Lems Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritis Annals of The Rheumatic Diseases 66 2007 958 961
69. S.J. Morris, M.C. Wasko, and J.L. Antohe Hydroxychloroquine use is associated with improvement in lipid profiles in rheumatoid arthritis patients Arthritis Care and Research 63 2010 530 534
70. P. Heeringa, and J.W. Tervaert Role of oxidized low-density lipoprotein in renal disease Current Opinion In Nephrology and Hypertension 11 2002 287 293
71. M. Van Leeuwen, J. Damoiseaux, A. Duijvestijn, and J.W. Tervaert The therapeutic potential of targeting B cells and anti-oxLDL antibodies in atherosclerosis Autoimmunity Reviews 9 2009 53 57
72. P. Gounopoulos, E. Merki, L.F. Hansen, S.H. Choi, and S. Tsimikas Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease Minerva Biotecnol 55 2007 821 837
73. M.C. Slot, R. Theunissen, P. van Paassen, J.G. Damoiseaux, J.W. Tervaert Limburg Nephrology Working Group Anti-oxidized low-density lipoprotein antibodies in myeloperoxidase-positive vasculitis patients preferentially recognize hypochlorite-modified low density lipoproteins Clinical and Experimental Immunology 149 2007 257 264
74. J. Frostegard Low level natural antibodies against phosphorylcholine: a novel risk marker and potential mechanism in atherosclerosis and cardiovascular disease Clinical Immunology 134 2010 47 54
75. G. Nesher, Y. Berkun, M. Mates, M. Baras, A. Rubinow, and M. Sonnenblick Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis Arthritis and Rheumatism 50 2004 1332 1337
76. M.S. Lee, S.D. Smith, A. Galor, and G.S. Hoffman Antiplatelet and anticoagulant therapy in patients with giant cell arteritis Arthritis and Rheumatism 54 2006 3306 3309
77. A.W. de Souza, N.P. Machado, V.M. Pereira, A.E. Arraes, E.T. Reis Neto, and H.A. Mariz Antiplatelet therapy for the prevention of arterial ischemic events in Takayasu arteritis Circulation Journal 74 2010 1236 1241
78. C. Salvarani, C. Della Bella, L. Cimino, P. Macchioni, D. Formisano, and G. Bajocchi Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis Rheumatology (Oxford) 48 2009 250 253
79. C.T. Berger, M. Wolbers, P. Meyer, T. Daikeler, and C. Hess High incidence of severe ischaemic complications in patients with giant cell arteritis irrespective of platelet count and size, and platelet inhibition Rheumatology (Oxford) 48 2009 258 261
80. M. Rubenfire, R.D. Brook, and R.S. Rosenson Treating mixed hyperlipidemia and the atherogenic lipid phenotype for prevention of cardiovascular events American Journal of Medicine 123 2010 892 898
81. Y.S. Chatzizisis, K.C. Koskinas, G. Misirli, C. Vaklavas, A. Hatzitolios, and G.D. Giannoglou Risk factors and drug interactions predisposing to statin-induced myopathy: implications for risk assessment, prevention and treatment Drug Safety 33 2010 171 187
82. H.J. de Jong, J.W. Tervaert, S.R. Saldi, R.J. Vandebriel, P.C. Souverein, and R.H. Meyboom Association between statin use and lupus-like syndrome using spontaneous reports Seminars In Arthritis and Rheumatism 41 2011 373 381
83. H.J. de Jong, O.H. Klungel, L. van Dijk, R.J. Vandebriel, H.G. Leufkens, and J.W. van der Laan Use of statins is associated with an increased risk of rheumatoid arthritis Annals of The Rheumatic Diseases 71 2012 648 654
84. H.J. de Jong, S.R. Saldi, O.H. Klungel, R.J. Vandebriel, P.C. Souverein, and R.H. Meyboom Statin-associated polymyalgia rheumatica. An analysis using WHO global individual case safety database: a case/non-case approach PLoS One 7 2012 e41289
85. G. Chodick, H. Amatil, Y. Shalem, E. Kokia, A.D. Heymann, and A. Porath Persistence with statins and onset of rheumatoid arthritis: a population-based cohort study PLoS Med 7 2010 e1000336
86. R.J. Vandebriel, H.J. De Jong, E.R. Gremmer, O.H. Klungel, J.W. Tervaert, and W. Slob Statins accelerate the onset of collagen type II-induced arthritis in mice Arthritis Research & Therapy 14 2012 R90